The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carreno, B. M.
Right arrow Articles by Coligan, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carreno, B. M.
Right arrow Articles by Coligan, J. E.

The Journal of Immunology, Vol 148, Issue 3 894-899, Copyright © 1992 by American Association of Immunologists


ARTICLES

Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide

BM Carreno, RV Turner, WE Biddison and JE Coligan
Molecular Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.

Viral epitopes that are recognized by both HLA class I-restricted and class II-restricted T cells have been defined for a type A influenza virus nucleoprotein (NP) peptide. CD8+ and CD4+ CTL lines have been generated against a synthetic peptide encompassing residues 335 to 349 of NP that are restricted by HLA-B37 and HLA-DQw5, respectively. Both of these CTL populations were capable of specifically lysing influenza A virus-infected targets, indicating that a naturally processed NP peptide(s) was being mimicked by the NP (335-349) peptide. Amino acid residues that are critical for recognition of this NP determinant in the context of HLA-B37 and HLA-DQw5 were investigated by the use of panels of truncated and alanine-substituted NP peptides. The results demonstrate that: 1) truncations in the amino- or carboxy-terminal ends differentially affect CD8+ and CD4+ CTL recognition; 2) the NP (335- 349) sequence contains two octapeptide epitopes that share a core of six amino acid residues (NP 338-343); and 3) alanine substitutions at five of these residues abrogated recognition by at least one of the CD8+ and CD4+ CTL lines. Thus, these class I- and class II-restricted CTL lines recognize similar but distinct epitopes, and different structural features of the NP peptide are required for presentation by HLA-B37 and HLA-DQw5. Comparison of the amino acid sequences of the NP peptide presented by HLA-B37 and HLA-DQw5 with other peptides known to be presented by both class I and class II molecules revealed a common motif among these peptides.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Truscott, X. Wang, L. Lybarger, W. E. Biddison, C. McBerry, J. M. Martinko, J. M. Connolly, G. P. Linette, D. H. Fremont, T. H. Hansen, et al.
Human Major Histocompatibility Complex (MHC) Class I Molecules with Disulfide Traps Secure Disease-related Antigenic Peptides and Exclude Competitor Peptides
J. Biol. Chem., March 21, 2008; 283(12): 7480 - 7490.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. May, T. Dao, J. Pinilla-Ibarz, T. Korontsvit, V. Zakhaleva, R. H. Zhang, P. Maslak, and D. A. Scheinberg
Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells
Clin. Cancer Res., August 1, 2007; 13(15): 4547 - 4555.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Senger, F. Maurano, M. F. Mazzeo, M. Gaita, O. Fierro, C. S. David, R. Troncone, S. Auricchio, R. A. Siciliano, and M. Rossi
Identification of Immunodominant Epitopes of {alpha}-Gliadin in HLA-DQ8 Transgenic Mice following Oral Immunization
J. Immunol., December 15, 2005; 175(12): 8087 - 8095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Kennedy, A. H. Undale, W. C. Kieper, M. S. Block, L. R. Pease, and E. Celis
Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses
J. Immunol., April 1, 2005; 174(7): 3967 - 3977.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Quinn, M. F. McInerney, and E. E. Sercarz
MHC Class I-Restricted Determinants on the Glutamic Acid Decarboxylase 65 Molecule Induce Spontaneous CTL Activity
J. Immunol., August 1, 2001; 167(3): 1748 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Linnemann, G. Jung, and P. Walden
Detection and Quantification of CD4+ T Cells with Specificity for a New Major Histocompatibility Complex Class II-Restricted Influenza A Virus Matrix Protein Epitope in Peripheral Blood of Influenza Patients
J. Virol., September 15, 2000; 74(18): 8740 - 8743.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
T. Ben-Yedidia, H. Marcus, Y. Reisner, and R. Arnon
Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
Int. Immunol., July 1, 1999; 11(7): 1043 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Jameson, J. Cruz, and F. A. Ennis
Human Cytotoxic T-Lymphocyte Repertoire to Influenza A Viruses
J. Virol., November 1, 1998; 72(11): 8682 - 8689.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Correale, K. Walmsley, S. Zaremba, M. Zhu, J. Schlom, and K. Y. Tsang
Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide
J. Immunol., September 15, 1998; 161(6): 3186 - 3194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.